These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 21377690)

  • 21. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
    Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
    Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients.
    Schramm E; Schneider D; Zobel I; van Calker D; Dykierek P; Kech S; Härter M; Berger M
    J Affect Disord; 2008 Jul; 109(1-2):65-73. PubMed ID: 18067973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder.
    Demyttenaere K; Andersen HF; Reines EH
    Int Clin Psychopharmacol; 2008 Sep; 23(5):276-86. PubMed ID: 18703937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.
    Barrett JE; Williams JW; Oxman TE; Frank E; Katon W; Sullivan M; Hegel MT; Cornell JE; Sengupta AS
    J Fam Pract; 2001 May; 50(5):405-12. PubMed ID: 11350703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of depression relapse: re-initiation of duloxetine treatment or dose increase.
    Fava M; Detke MJ; Balestrieri M; Wang F; Raskin J; Perahia D
    J Psychiatr Res; 2006 Jun; 40(4):328-36. PubMed ID: 16678205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluoxetine once every third day in the treatment of major depressive disorder.
    Tural U; Onder E
    Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can elderly patients who have had a hip fracture perform moderate- to high-intensity exercise at home?
    Mangione KK; Craik RL; Tomlinson SS; Palombaro KM
    Phys Ther; 2005 Aug; 85(8):727-39. PubMed ID: 16048421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study.
    Akkaya C; Sivrioglu EY; Akgoz S; Eker SS; Kirli S
    Hum Psychopharmacol; 2006 Jul; 21(5):337-45. PubMed ID: 16856215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of structured exercise and pharmacotherapy vs. pharmacotherapy for adults with depressive symptoms: A randomized clinical trial.
    Carneiro LS; Fonseca AM; Vieira-Coelho MA; Mota MP; Vasconcelos-Raposo J
    J Psychiatr Res; 2015 Dec; 71():48-55. PubMed ID: 26522871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study.
    Kim JM; Kim SW; Stewart R; Kim SY; Yoon JS; Jung SW; Lee MS; Yim HW; Jun TY
    Hum Psychopharmacol; 2011 Jan; 26(1):41-50. PubMed ID: 21344501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise and pharmacotherapy in the treatment of major depressive disorder.
    Blumenthal JA; Babyak MA; Doraiswamy PM; Watkins L; Hoffman BM; Barbour KA; Herman S; Craighead WE; Brosse AL; Waugh R; Hinderliter A; Sherwood A
    Psychosom Med; 2007; 69(7):587-96. PubMed ID: 17846259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintained superiority of chronotherapeutics vs. exercise in a 20-week randomized follow-up trial in major depression.
    Martiny K; Refsgaard E; Lund V; Lunde M; Thougaard B; Lindberg L; Bech P
    Acta Psychiatr Scand; 2015 Jun; 131(6):446-57. PubMed ID: 25689725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease.
    Swardfager W; Herrmann N; Marzolini S; Saleem M; Farber SB; Kiss A; Oh PI; Lanctôt KL
    J Clin Psychiatry; 2011 Sep; 72(9):1181-8. PubMed ID: 21208573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ACTIVEDEP: a randomised, controlled trial of a home-based exercise intervention to alleviate depression in middle-aged and older adults.
    Pfaff JJ; Alfonso H; Newton RU; Sim M; Flicker L; Almeida OP
    Br J Sports Med; 2014 Feb; 48(3):226-32. PubMed ID: 23833045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.